![[Audio] BT18 Topical Interaction 05 - Anorexia and Bulimia Nervosa: Is a Brief Treatment Possible? - Camillo Loriedo](https://wsolib.com/wp-content/uploads/2023/06/Audio-Only-BT18-Topical-Interaction-05-Anorexia-and-Bulimia-Nervosa-Is-a-Brief-Treatment-Possible-Camillo-Loriedo-MD-PhD.png "[Audio] BT18 Topical Interaction 05 - Anorexia and Bulimia Nervosa: Is a Brief Treatment Possible? - Camillo Loriedo, MD, PhD - WSO.lib")
[Audio] BT18 Topical Interaction 05 – Anorexia and Bulimia Nervosa: Is a Brief Treatment Possible? – Camillo Loriedo, MD, PhD
Original price was: $15.00.$9.00Current price is: $9.00.
Unlock your potential with the [Audio] BT18 Topical Interaction 05 - Anorexia and Bulimia Nervosa: Is a Brief Treatment Possible? - Camillo Loriedo, MD, PhD course for only Original price was: $15.00.$9.00Current price is: $9.00. at WSOLib.com! Discover our vast library of over 60,000 downloadable digital courses across Health and Medical. Get expert-guided, self-paced learning and save over 80% compared to retail prices. Transform your skills today!
Salepage link: At HERE. Archive:
- Topic Areas:
- Topical Interaction
- Category:
- Brief Therapy Conference | Brief Therapy Conference 2018
- Faculty:
- Camillo Loriedo, MD, PhD
- Duration:
- 1:00:27
- Format:
- Audio Only
- Original Program Date :
- Dec 08, 2018
Description
Description:
Various attempts to treat these disturbances briefly have been made, but in most cases they proved to be unsuccessful due a very high relapse rate. To avoid a fearsome chronicity, a number of other factors, like alexithymia, low self-esteem, perfectionism, dissociation, dichotomous thinking, and others should be considered for treatment. Indications of how to deal with these factors in Ericksonian Brief Therapy will be offered.
Educational Objectives:
- List nine factors that can enhance the risk of chronicity in Eating Disorders.
- Describe five different strategies to make the treatment of Anorexia and Bulimia brief.
*Sessions may be edited for content and to preserve confidentiality*
Faculty
Camillo Loriedo, MD, PhD Related seminars and products: 38
CAMILLO LORIEDO, MD PhD, is professor of Psychiatry and Psychotherapy at the University of Rome, School of Medicine and the School of Specialization. Since 1998, he has been a member of the Board of Directors of the Milton Erickson Foundation. He has recently been elected President of the Italian Society of Psychotherapy. Since 2005, he has been a member of the Editorial Board of the American Journal of Clinical Hypnosis. Loriedo has been awarded the Milton H. Erickson Lifetime Achievement Award for outstanding contributions to the field of Psychotherapy. He has authored over 350 scientific papers and 26 books.
Secure your future with the [Audio] BT18 Topical Interaction 05 - Anorexia and Bulimia Nervosa: Is a Brief Treatment Possible? - Camillo Loriedo, MD, PhD course at WSOLib.com! Gain lifetime access to expertly curated content, empowering your career and personal development.
- Lifetime Access: Enjoy unlimited access to your digital courses.
- Huge Savings: Prices are consistently up to 80% lower than original sales pages.
- Secure Transactions: Shop with confidence using our trusted payment methods.
- Actionable Knowledge: Acquire real-world skills from diverse topics.
- Instant Delivery: Start learning immediately after purchase.
- Device Flexibility: Access your courses on desktop, mobile, or tablet.
Begin your learning journey with WSOLib.com!
Specification: [Audio] BT18 Topical Interaction 05 – Anorexia and Bulimia Nervosa: Is a Brief Treatment Possible? – Camillo Loriedo, MD, PhD
|
User Reviews
Only logged in customers who have purchased this product may leave a review.
![[Audio] BT18 Topical Interaction 05 – Anorexia and Bulimia Nervosa: Is a Brief Treatment Possible? – Camillo Loriedo, MD, PhD](https://wsolib.com/wp-content/uploads/thumbs_dir/Audio-Only-BT18-Topical-Interaction-05-Anorexia-and-Bulimia-Nervosa-Is-a-Brief-Treatment-Possible-Camillo-Loriedo-MD-PhD-q8okzcc5imiwlat9t2zpg0j0w5te5i2xgkln08kik4.png)
There are no reviews yet.